Francesco Saraceni

Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse

Noga Shem‐Tov, Francesco Saraceni, Ivetta Danylesko et al. · Biology of Blood and Marrow Transplantation · 2017 · 71 citations · Full text

Medicine, Hematology, Oncology +17

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT

Carmelo Gurnari, Linda Köster, Laurien Baaij et al. · Blood Advances · 2024 · 61 citations · Full text

Medicine, Hematology, Stem Cell Transplantation +8

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission

Francesco Saraceni, Myriam Labopin, Rose-Marie Hamladji et al. · Oncotarget · 2017 · 52 citations · Full text

Medicine, Hematology, Oncology +13

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score

Jacopo Olivieri, Immacolata Attolico, Roberta Nuccorini et al. · Bone Marrow Transplantation · 2018 · 47 citations · Full text

Medicine, Biostatistics, Hematology +14

Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT

Francesco Saraceni, Myriam Labopin, Norbert Claude Gorin et al. · Journal of Hematology & Oncology · 2016 · 40 citations · Full text

Medicine, Biostatistics, Hematology +17